Neonatal systemic thromboembolism secondary to ductus arteriosus aneurysm and patent foramen ovale.

Congenit Heart Dis

Department of Radiology Pediatrics, Wake Forest Baptist Health School of Medicine, Medical Center Blvd, Winston-Salem, NC, USA.

Published: August 2013

AI Article Synopsis

Article Abstract

Ductus arteriosus aneurysm (DAA) can be associated with neonatal thromboembolism. We report a neonate with systemic thromboembolism causing acute cerebral infarction with DAA, arterial, and venous thrombosis, discovered on CT angiography. The role of DAA was suspected as a potential etiology of systemic thromboembolism in this case. CT angiography with three-dimensional reconstruction was valuable delineating the adjunctive vascular structures. Screening for presence of DAA may be considered in the neonatal thromboembolism.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1747-0803.2011.00555.xDOI Listing

Publication Analysis

Top Keywords

systemic thromboembolism
12
ductus arteriosus
8
arteriosus aneurysm
8
neonatal thromboembolism
8
thromboembolism
5
neonatal systemic
4
thromboembolism secondary
4
secondary ductus
4
aneurysm patent
4
patent foramen
4

Similar Publications

Septic pelvic thrombophlebitis is defined as an endovascular thrombus of infectious etiology. It is frequently diagnosed only after excluding other more common pathologies. A high level of suspicion should be maintained in the context of a fever refractory to broad-spectrum antibiotics that improves after initiation of systemic anticoagulation.

View Article and Find Full Text PDF

Background: COVID-19 is associated with intense systemic inflammation and abnormal coagulation profile leading to an increased incidence of pulmonary embolism (PE). This study investigates whether PE in COVID-19 patients has different clinical, laboratory and radiological characteristics when compared to traditional PE in COVID negative patients.

Methods: We conducted an observational, multicentric, cross-sectional study on consecutive patients diagnosed with PE at admission or during hospital stay from February 21 2019 to February 20 2021.

View Article and Find Full Text PDF

Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, is a significant burden on health and economic systems worldwide. Improved VTE management calls for the integration of biomarkers into diagnostic algorithms and scoring systems for risk assessment, possible complications, and mortality. This literature review discusses novel biomarkers with potential diagnostic and prognostic value in personalized VTE management.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical atrial fibrillation (AF) significantly raises the risk of stroke and systemic embolism, but treatment with oral anticoagulants can lower this risk while increasing the chance of major bleeding.
  • Device-detected atrial fibrillation (DDAF) also poses a stroke risk, though lower than clinical AF, with studies showing that direct oral anticoagulation can reduce stroke risk for DDAF patients but similarly heightens bleeding risk.
  • The challenge persists in determining how to effectively manage the balance between reducing thromboembolic risk and the increased risk of bleeding for DDAF patients, as well as identifying those who would benefit most from anticoagulant therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!